VNS Algorithm for Advanced Dosing

Sex: All

Ages: 18 Years – 75 Years

Healthy volunteers: No

Phase: NA

Enrollment: 80

Sponsor: Fernando Vale

Summary

The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is: Does the modified programming of the VNS reduce seizures faster than the standard programming? Participants in both groups will: 1. Attend up to 3 study visits every 3 months for 2 years 2. Answer questionnaires to assess quality of life and cognitive function 3. Maintain a diary of seizure activity

Eligibility Criteria

Inclusion Criteria: * Subjects who are clinically determined to be candidates for VNS implantation for seizure control * Subject/legally authorized representative able to provide informed consent. Exclusion Criteria: * Subjects with VNS system treating pathologies other than drug refractory epilepsy or medical co-morbidities that prevent any surgical intervention

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07725601). StuddyBuddy aggregates publicly available trial information.